Mass spectrometry-based analysis of glycoproteins and its clinical applications in cancer biomarker discovery

被引：33
|
作者：
Liu, Huan [1 ,2 ]
Zhang, Ningbo [1 ,2 ]
Wan, Debin [1 ,2 ]
Cui, Meng [1 ]
Liu, Zhiqiang [1 ]
Liu, Shuying [1 ]
机构：
[1] Chinese Acad Sci, Changchun Inst Appl Chem, Changchun Ctr Mass Spectrometry, 5625 Renmin St, Changchun 130022, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100039, Peoples R China
来源：
CLINICAL PROTEOMICS | 2014年 / 11卷
基金：
中国国家自然科学基金;
关键词：
Mass spectrometry; Glycoproteins; Cancer biomarker; ELECTRON DETACHMENT DISSOCIATION; N-LINKED GLYCOPROTEINS; NANO-LC-MS/MS; STRUCTURAL-CHARACTERIZATION; PROTEIN GLYCOSYLATION; QUANTITATIVE-ANALYSIS; LIVER-CANCER; IDENTIFICATION; SERUM; GLYCANS;
D O I：
10.1186/1559-0275-11-14
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Glycosylation is one of the most important posttranslational modifications of proteins and plays essential roles in various biological processes. Aberration in the glycan moieties of glycoproteins is associated with many diseases. It is especially critical to develop the rapid and sensitive methods for analysis of aberrant glycoproteins associated with diseases. Mass spectrometry (MS) has become a powerful tool for glycoprotein analysis. Especially, tandem mass spectrometry can provide highly informative fragments for structural identification of glycoproteins. This review provides an overview of the development of MS technologies and their applications in identification of abnormal glycoproteins and glycans in human serum to screen cancer biomarkers in recent years.
引用
收藏
页数：9
相关论文
共 50 条
  • [41] Label-free mass spectrometry-based proteomics for biomarker discovery and validation
    Pham, Thang V.
    Piersma, Sander R.
    Oudgenoeg, Gideon
    Jimenez, Connie R.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2012, 12 (04) : 343 - 359
  • [42] Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research
    Zhang, Aihua
    Sun, Hui
    Yan, Guangli
    Wang, Ping
    Wang, Xijun
    BIOMEDICAL CHROMATOGRAPHY, 2016, 30 (01) : 7 - 12
  • [43] Drug profiling and biomarker discovery using mass spectrometry-based proteomics technologies
    Jenne, A.
    Tebbe, A.
    Schaab, C.
    Godl, K.
    Kaminski, M.
    Mueller, S.
    JOURNAL OF BIOTECHNOLOGY, 2010, 150 : S29 - S29
  • [44] Application of multiple statistical tests to enhance mass spectrometry-based biomarker discovery
    Niclas C Tan
    Wayne G Fisher
    Kevin P Rosenblatt
    Harold R Garner
    BMC Bioinformatics, 10
  • [45] Application of multiple statistical tests to enhance mass spectrometry-based biomarker discovery
    Tan, Niclas C.
    Fisher, Wayne G.
    Rosenblatt, Kevin P.
    Garner, Harold R.
    BMC BIOINFORMATICS, 2009, 10
  • [46] Integrated mass spectrometry-based analysis of plasma glycoproteins and their glycan modifications
    Wang, Hong
    Wong, Chee-Hong
    Chin, Alice
    Taguchi, Ayumu
    Taylor, Allen
    Hanash, Samir
    Sekiya, Sadanori
    Takahashi, Hidenori
    Murase, Masaki
    Kajihara, Shigeki
    Iwamoto, Shinichi
    Tanaka, Koichi
    NATURE PROTOCOLS, 2011, 6 (03) : 253 - 269
  • [47] Mass Spectrometry-Based Protein Biomarker Discovery and Measurement: Sensitivity is the Greatest Hurdle
    Lance A. Liotta
    Emanuel F. Petricoin
    Clinical Proteomics, 2010, 6 (1-2) : 4 - 5
  • [48] Mass spectrometry-based discovery of secretome biomarkers for ovarian cancer
    Rocconi, R. P.
    Zhang, G.
    Shevde, L. A.
    Samant, R. S.
    Finan, M. A.
    Pannell, L. K.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S54 - S55
  • [49] Mass spectrometry-based extracellular vesicle micromolecule detection in cancer biomarker discovery: An overview of metabolomics and lipidomics
    Bai, Liyi
    Bu, Fanqin
    Li, Xiangji
    Zhang, Shutian
    Min, Li
    VIEW, 2023, 4 (05)
  • [50] Mass spectrometry-based proteomics of fungal wall glycoproteins
    Yin, Qing Yuan
    de Groot, Piet W. J.
    de Koster, Chris G.
    Klis, Frans M.
    TRENDS IN MICROBIOLOGY, 2008, 16 (01) : 20 - 26
12345